National Data Opt-out
A national data opt-out is being introduced from 25 May 2018. Communications about the national data opt-out aim to make sure that people can make an informed choice about how their confidential patient information is used for research and planning NHS and care services. The NHS is communicating to patients, public and workforce about the national data
Changes to Local Clinical Excellence Awards
NHS Employers and the BMA have agreed changes to the Local Clinical Excellence Awards (LCEAs) Scheme. The changes, which are endorsed by the Department of Health and Social Care, state that: trusts must run LCEA rounds from 1 April 2018 from 1 April 2018 to 31 March 2021, the minimum investment ratio for new LCEA will
WCSM: Submissions invited for the 2018 Ruskell Medal and Master’s Medal.
The Worshipful Company of Spectacle Makers is now inviting submissions for these two esteemed competitions, which each year attract significant interest from UK research students and departments. The winner of each medal will receive a prize of £750 and will also be invited to the Company’s Court Luncheon at Apothecaries’ Hall on Wednesday 3rd October
Ophthalmic Safety Alert – detachment of cannulas during ophthalmic surgery
The NHS Improvement national patient safety team have informed the College of the continued trend of incidents involving issues with detachment of cannulas during ophthalmic surgery (cannula-associated ocular injury, COI). The cannula is usually attached to either a saline or a viscoelastic syringe. The combination of a small lumen and plunger pressure can result in
Eye health sector launches new SAFE approach to assist in improving the systems around the delivery of eye health and sight loss services in England
The Clinical Council for Eye Health Commissioning (CCEHC), which represents the leading clinical professions and sight loss charity organisations in the eye-care sector, has launched a new Systems and Assurance Framework for Eye-health (SAFE)1. Increasing demands on eye health services due to the ageing population and the availability of new treatments continue to create capacity